Journal Information
Vol. 115. Issue 5.
Pages T503 (May 2024)
Share
Share
Download PDF
More article options
Vol. 115. Issue 5.
Pages T503 (May 2024)
Images in Dermatology
Full text access
Eruptive Lentiginosis After Resolution of Severe Atopic Dermatitis
Lentiginosis eruptiva tras resolución de dermatitis atópica severa
Visits
1882
Á. Aguado-Vázquez
Corresponding author
alvaroav1111@gmail.com

Corresponding author.
, J.M. Sánchez-Motilla, A. Mateu-Puchades
Servicio de Dermatología, Hospital Universitario Doctor Peset, Valencia, España
Related content
Actas Dermosifiliogr. 2024;115:50310.1016/j.ad.2023.02.029
Á. Aguado-Vázquez, J.M. Sánchez-Motilla, A. Mateu-Puchades
This item has received
Article information
Full Text
Download PDF
Statistics
Figures (2)
Full Text

A 24-year-old woman with severe childhood-onset atopic dermatitis had received multiple treatments with incomplete responses in most cases. The last treatment received was tralokinumab, which almost completely resolved her eczematous plaques and lichenification, leaving numerous pigmented lesions behind consistent with lentigines limited to the areas of the previous eczematous plaques (figure 1).

Figure 1
(0.04MB).

Dermoscopy showed a reticular pattern of thin and delicate lines with fingerprint-like structures, characteristic of lentigines in the absence of typical features such as dots, globules, and other structures typical of melanocytic nevi (figure 2). No histopathological examination was performed for the absence of atypia or malignancy signs. Finally, a conclusive diagnosis of lentigines was established based on clinical and dermoscopic findings.

Figure 2
(0.03MB).

This phenomenon—well-documented in patients with psoriasis—is much less common in patients with atopic dermatitis and has been scarcely described in the scientific medical literature.

It is considered a benign phenomenon due to the chronic damage caused by the underlying disease to the affected skin, leading to increased cell turnover and subsequent proliferation of melanocytes. It has been primarily associated with the use of topical calcineurin inhibitors, and with the prolonged use of topical corticosteroids or biologic drugs. In our patient, as in most published cases, this lentiginosis probably had a multifactorial origin, with chronic damage and the use of these treatments contributing to its development.

Funding

None declared.

Copyright © 2023. AEDV
Download PDF
Idiomas
Actas Dermo-Sifiliográficas
Article options
Tools
es en

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?